The novel coronavirus COVID-19 has created massive disruptions throughout the world, and the Federal Government has not been exempt. Most workers are beginning to work from home, all conferences and large meetings in the next 8 weeks are likely to be cancelled or postponed. We still don’t know what affect these disruptions will have on SBIR/STTR reviews and awards, but it’s safe to say there will be delays, postponements, and other obstacles.
With this in mind, we have decided to create this page as a general repository of resources and information related to the SBIR/STTR programs and the COVID-19 disease and its effects. This page includes links to helpful resources and articles, list of delays and cancellations, and SBIR/STTR funding opportunities arising from the oubreak.
This is a fluidly developing situation, so we will update this post with more resources and information as they become available. If you come across information or resources that you think would be helpful to the SBIR/STTR community, please email it to email@example.com so that we can include it on this page.
Also be sure to visit NSBA’s COVID-19 site for more info & resources for small businesses
Last Updated: April 1
SBIR/STTR COVID-19 Resources
- DOD A&S Under Sec Lord Memo on Defense Industrial Base work during COVID-19 Restrictions
- Impact on NASA SBIR (Phase I Proposal due date postponed until April 20)
- Information for NIH Applicants and Recipients of NIH Funding
- NIH National Cancer Institute Funding & Submission Notices Related to COVID-19
- DARPA FAQ about COVID-19
SBIR/STTR & COVID-19 in the news
March 20: SBIR Road Tour Dates Postponed
The Assistant Secretary of the Navy James Guertz released a memo encouraging the Navy to engage the R&D industrial base for support of the COVID-19 pandemic response. The memo urges “maximum consideration” to opportunities to SBIR and startup firms.
The National Institute of General Medical Sciences (NIHMS) issued this notice indicating they will accept the submission of applications for Competitive Revisions to active grants to address only areas related to COVID-19 and SARS-CoV-2. NIHMS will also only consider SBIR/STTR grants for the following topics:
- Repurposing or modification of diagnostic tools currently under development to enable rapid detection of SARS-CoV-2 infection (SBIR/STTR grants only).
- Rapid development of potential therapeutic agents for COVID-19 (SBIR/STTR only)
SBIR/STTR Office Social Media
(Note: not all SBIR offices are active on Social Media)